Vitae Pharmaceuticals' P2P Acquisition

Vitae Pharmaceuticals raised a round of funding on October 24, 2016. Investors include Allergan.

Vitae Pharmaceuticals is a clinical stage biopharmaceutical company discovering and developing a portfolio of small molecule compounds that address disease areas, including: chronic kidney disease, di…

Articles about Vitae Pharmaceuticals' P2P Acquisition: